# MBIO (Mustang Bio, Inc.) - SEC EDGAR Financial Statements

> Mustang Bio, Inc. reported $14.68M in total assets and a net loss of $3.53M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MBIO
- Markdown: https://convexityos.com/fundamentals/MBIO.md
- SEC CIK: 0001680048
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001680048&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$3.96M | Operating profit |
| Net Income | FY 2025 | -$3.53M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.52 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $14.28M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | $7.56M | $40.51M | $62.48M | $49.86M | $37.24M | $30.04M | $2.10M | $100K | $2.00M |
| Total Operating Expenses | $2.43M | $16.25M | $49.26M | $76.16M | $66.72M | $56.81M | $45.88M | $31.22M | $31.79M | $11.36M |
| **Operating Income** | -$2.43M | -$16.25M | -$49.26M | -$76.16M | -$66.72M | -$56.81M | -$45.88M | -$31.22M | -$31.79M | -$11.36M |
| **EBITDA** | -$2.40M | -$15.57M | -$47.40M | -$73.44M | -$64.56M | -$55.13M | -$44.63M | -$30.59M | -$31.78M | -$11.36M |
| Interest Income | $511K | $179K | $850K | $689K | $368K | $708K | $1.26M | $569K | $505K | $16K |
| Interest Expense | -- | $5.0K | $4.11M | $3.36M | $15K | $3.92M | $1.77M | $8.0K | $8.0K | $895K |
| Income Before Tax | -$1.92M | -$15.75M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $27K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$1.92M | -$15.75M | -$51.60M | -$77.53M | -$66.37M | -$60.02M | -$46.39M | -$30.66M | -$31.29M | -$12.65M |
| Basic EPS | -$0.39 | -$38.57 | -$16,126.34 | -$1,808.24 | -$26,259.78 | -$39,389.67 | -$44,572.52 | -$39,389.67 | -$42,844.90 | -$39,735.19 |
| **Diluted EPS** | -$0.39 | -$38.57 | -$16,126.34 | -$1,808.24 | -$26,259.78 | -$39,389.67 | -$44,572.52 | -$39,389.67 | -$42,844.90 | -$39,735.19 |
| Basic Shares Outstanding | 4.9M | 609.7K | 3.2K | 42.9K | 2.5K | 1.5K | 1.0K | 780 | 731 | 319 |
| Diluted Shares Outstanding | 4.9M | 609.7K | 3.2K | 42.9K | 2.5K | 1.5K | 1.0K | 780 | 731 | 319 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | -- | -- | -- | -- | -- | -- | -$664K |
| Total Operating Expenses | $1.06M | $1.17M | $1.06M | $670K | $624K | $885K | $253K | $1.02M |
| **Operating Income** | -$1.06M | -$1.17M | -$1.06M | -$670K | -$624K | -$885K | -$253K | -$1.02M |
| **EBITDA** | -$1.06M | -$1.17M | -$1.06M | -$670K | -$624K | -$885K | -$219K | -$966K |
| Interest Income | $94K | $98K | $103K | $132K | $156K | $123K | $100K | $65K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $1.0K |
| **Net Income** | -$964K | -$1.07M | -$955K | -$538K | -$468K | -$762K | -$153K | -$952K |
| Basic EPS | -$0.14 | -$0.16 | -$0.14 | -- | -$0.07 | -$0.19 | -$0.05 | -- |
| **Diluted EPS** | -$0.14 | -$0.16 | -$0.14 | -- | -$0.07 | -$0.19 | -$0.05 | -- |
| Basic Shares Outstanding | 6.7M | 6.7M | 6.7M | -- | 6.2M | 4.0M | 2.9M | -- |
| Diluted Shares Outstanding | 6.7M | 6.7M | 6.7M | -- | 6.2M | 4.0M | 2.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.27M | $6.84M | $6.23M | $75.66M | $109.6M | $97.80M | $61.41M | $16.47M | -- | $27.50M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | $0 | $17.60M | -- | -- |
| **Cash & Short-Term Investments** | $17.27M | $6.84M | $6.23M | $75.66M | $109.6M | $97.80M | $61.41M | $34.07M | -- | $27.50M |
| **Total Current Assets** | $17.59M | $8.61M | $11.35M | $78.85M | $111.7M | $99.53M | $63.06M | $35.12M | $61.36M | $27.50M |
| Property, Plant & Equipment, Net | $0 | $371K | $3.25M | $8.44M | $11.05M | $8.03M | $7.94M | $6.86M | $1.38M | $0 |
| Other Non-Current Assets | $0 | $250K | $833K | $261K | $362K | $250K | $250K | $271K | $251K | $0 |
| **Total Non-Current Assets** | $0 | $702K | $6.40M | $13.57M | $13.46M | $10.37M | $10.38M | $7.63M | $2.13M | $0 |
| **Total Assets** | $17.59M | $9.31M | $17.74M | $92.42M | $125.2M | $109.9M | $73.44M | $42.75M | $63.49M | $27.50M |
| Accounts Payable | $3.51M | $7.46M | $6.32M | $6.83M | $3.51M | $3.52M | $1.88M | $1.39M | -- | -- |
| Short-Term Debt | -- | -- | -- | -- | -- | $0 | $1.25M | $0 | -- | -- |
| Other Current Liabilities | $2.50M | $2.67M | $834K | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $7.91M | $12.61M | $15.37M | $15.11M | $10.81M | $9.52M | $7.77M | $5.62M | $3.61M | $3.22M |
| **Total Non-Current Liabilities** | $150K | $572K | $2.25M | $31.04M | $1.96M | $1.95M | $14.02M | $741K | $50K | $0 |
| **Total Liabilities** | $8.06M | $13.18M | $17.62M | $46.15M | $12.77M | $11.46M | $21.79M | $6.36M | $3.66M | $3.22M |
| **Total Debt (incl. Leases)** | -- | $900K | $2.50M | $3.90M | $2.00M | $2.20M | $3.35M | $0 | -- | -- |
| Common Stock | -- | -- | -- | -- | -- | $7.0K | $4.0K | $3.0K | $3.0K | $2.0K |
| Retained Earnings | -$398.6M | -$396.7M | -$381.0M | -$329.4M | -$251.8M | -$185.5M | -$125.5M | -$79.07M | -$48.41M | -$17.12M |
| **Total Stockholders' Equity** | $9.53M | -$3.87M | $123K | $46.27M | $112.4M | $98.44M | $51.65M | $36.40M | $59.83M | $24.28M |
| Total Equity | $9.53M | -$3.87M | $123K | $46.27M | $112.4M | $98.44M | $51.65M | $36.40M | $59.83M | $24.28M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14.28M | $15.15M | $16.26M | $17.27M | $18.98M | $12.66M | $14.23M | $6.84M |
| **Cash & Short-Term Investments** | $14.28M | $15.15M | $16.26M | $17.27M | $18.98M | $12.66M | $14.23M | $6.84M |
| **Total Current Assets** | -- | -- | -- | $17.59M | $19.36M | $13.05M | $14.91M | $8.61M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $0 | $0 | $0 | $371K |
| Other Non-Current Assets | -- | -- | -- | $0 | $0 | $0 | $0 | $250K |
| **Total Non-Current Assets** | -- | -- | -- | $0 | $0 | $0 | $0 | $702K |
| **Total Assets** | $14.68M | $15.61M | $16.58M | $17.59M | $19.36M | $13.05M | $14.91M | $9.31M |
| Accounts Payable | $3.12M | $3.21M | $3.34M | $3.51M | $4.99M | $5.65M | $6.31M | $7.46M |
| Other Current Liabilities | $2.53M | $2.54M | $2.52M | $2.50M | $2.53M | $2.50M | $2.81M | $2.67M |
| **Total Current Liabilities** | $7.95M | $7.92M | $7.84M | $7.91M | $9.44M | $10.00M | $11.15M | $12.61M |
| **Total Non-Current Liabilities** | $150K | $150K | $150K | $150K | $150K | $150K | $150K | $572K |
| **Total Liabilities** | $8.10M | $8.07M | $7.99M | $8.06M | $9.59M | $10.15M | $11.30M | $13.18M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | -- | -- | $900K |
| Retained Earnings | -$401.6M | -$400.7M | -$399.6M | -$398.6M | -$398.1M | -$397.6M | -$396.9M | -$396.7M |
| **Total Stockholders' Equity** | $6.59M | $7.54M | $8.60M | $9.53M | $9.77M | $2.89M | $3.61M | -$3.87M |
| Total Equity | $6.59M | $7.54M | $8.60M | $9.53M | $9.77M | $2.89M | $3.61M | -$3.87M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.92M | -$15.75M | -$51.60M | -$77.53M | -$66.37M | -$60.02M | -$46.39M | -$30.66M | -$31.29M | -$12.65M |
| Depreciation & Amortization | $34K | $671K | $1.86M | $2.72M | $2.17M | $1.68M | $1.26M | $630K | $2.0K | $0 |
| Stock-Based Compensation | $129K | -$450K | $568K | $2.28M | $3.31M | $2.99M | $2.66M | $4.96M | $2.01M | $0 |
| **Operating Cash Flow** | -$5.26M | -$11.41M | -$49.48M | -$65.07M | -$53.67M | -$37.32M | -$33.58M | -$19.24M | -$12.95M | -$4.13M |
| Capital Expenditure | -- | $0 | -$64K | -$2.71M | -$3.99M | -$1.93M | -$2.35M | -$6.87M | -$424K | -- |
| **Free Cash Flow** | -- | -$11.41M | -$49.54M | -$67.78M | -$57.65M | -$39.24M | -$35.93M | -$26.11M | -$13.37M | -- |
| **Investing Cash Flow** | $1.17M | $0 | $5.89M | -$2.95M | -$5.37M | -$4.41M | $13.91M | $557K | -$29.05M | $0 |
| Common Stock Issued | -- | $6.51M | $4.40M | -- | $0 | $37.23M | $31.62M | $0 | $50.30M | $35.01M |
| **Financing Cash Flow** | $14.53M | $11.27M | -$26.08M | $34.06M | $70.85M | $78.12M | $65.12M | $181K | $49.98M | $31.63M |
| **Net Change in Cash** | $10.43M | -$145K | -$69.67M | -$33.96M | $11.81M | $36.39M | $45.44M | -$18.51M | $7.98M | $27.50M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$964K | -$1.07M | -$955K | -$538K | -$468K | -$762K | -$153K | -$952K |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $0 | $34K | $51K |
| Stock-Based Compensation | $2.0K | $21K | $22K | $23K | $23K | $45K | $38K | $50K |
| **Operating Cash Flow** | -$876K | -$967K | -$1.01M | -$1.72M | -$818K | -$1.34M | -$1.39M | -$2.00M |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | $1.17M | $0 |
| **Financing Cash Flow** | $2.0K | -$141K | $0 | $0 | $7.14M | -$235K | $7.62M | $4.94M |
| **Net Change in Cash** | -$874K | -$1.11M | -$1.01M | -$1.72M | $6.33M | -$1.57M | $7.39M | $2.94M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -20.2% | -- | -41952.8% | -167.5% | -59.0% | -61.0% | -89.8% | -84.2% | -52.3% | -52.1% |
| Return on Assets (ROA) | -10.9% | -169.2% | -290.8% | -83.9% | -53.0% | -54.6% | -63.2% | -71.7% | -49.3% | -46.0% |
| Current Ratio | 2.22x | 0.68x | 0.74x | 5.22x | 10.33x | 10.46x | 8.12x | 6.25x | 16.99x | 8.53x |
| Quick Ratio | 2.18x | 0.54x | 0.41x | 5.01x | 10.14x | 10.28x | 7.90x | 6.07x | -- | 8.53x |
| Debt to Equity | -- | -- | 20.33x | 0.08x | 0.02x | 0.02x | 0.06x | 0.00x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -53.6% | -40.2% | -31.7% | -20.2% | -23.9% | -113.3% | -296.9% | -- |
| Return on Assets (ROA) | -24.0% | -19.4% | -16.4% | -10.9% | -12.1% | -25.1% | -71.9% | -169.2% |
| Current Ratio | -- | -- | -- | 2.22x | 2.05x | 1.30x | 1.34x | 0.68x |
| Quick Ratio | 1.80x | 1.91x | 2.07x | 2.18x | 2.01x | 1.27x | 1.28x | 0.54x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
